Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_assertion type Assertion NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_head.
- NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_assertion wasGeneratedBy ECO_0000203 NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_provenance.
- NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_assertion wasDerivedFrom befree-20140225 NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_provenance.
- NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_assertion SIO_000772 19123475 NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_provenance.
- NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_assertion evidence source_evidence_literature NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_provenance.
- NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_assertion description "[Nude mice with HNSCC solid tumor xenografts were treated with Sal-B (80 mg/kg/day) or celecoxib (5 mg/kg/day) for 25 days to investigate in vivo effects of the COX-2 inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685981.RAYQb2wnliMEF-FfMvwYzeYaBx4735RwBOwRvfWKQrpm0130_provenance.